Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

50 ML ofatumumab 20 MG/ML Injection [Arzerra]

Known as: OFATUMUMAB 20 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [ARZERRA], Arzerra 1000 MG in 50 ML Injection, OFATUMUMAB 20 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [ARZERRA]_#2 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Der CHMP verabschiedete – zwei Zulassungsempfehlungen inkl. Pharmakovigilanzplänen für folgende Arzneimittel: • Arepanrix… Expand
Is this relevant?
Review
2010
Review
2010
On April 19, 2010, the European Commission issued a conditional marketing authorization valid throughout the European Union (EU… Expand
Is this relevant?